Shared Medicare Leads

The shared format permits a maximum of three buyers. Ask how the supplier counts recipients across direct delivery, affiliated distributors, retries, and replacement activity. A cap is useful only when the supplier can explain the unit being counted and preserve the allocation history associated with each inquiry. Do not interpret missing recipient information as confirmation that a record was distributed within the cap.

Your agreement should identify how an excess-allocation complaint is handled without exposing unnecessary information about other buyers. Request a record-level allocation reference and an investigation path. Keep the buyer cap separate from contact frequency: distribution to a limited set of organizations does not determine how often any organization may lawfully or appropriately contact the consumer.

A shared inquiry may arrive while the consumer is already speaking with another agency. Train agents to identify their own organization clearly and explain the inquiry they are responding to without implying ownership of the consumer’s request. The conversation should allow the person to clarify whether assistance is still wanted. Competitive urgency is not a reason to skip disclosures or preference checks.

Build a disposition for “working with another agency” that is distinct from an invalid record. Let suppression requests and contact preferences flow back to the systems that control future outreach. Avoid scripts suggesting that other callers are unauthorized or that your agency has a government-designated role. The distribution model should shape respectful handling, not pressure tactics.

Shared distribution outside the agency should not create uncontrolled duplication inside it. Match incoming records against existing contacts using documented rules, then preserve the original source and permission history. Where records conflict, flag them for review instead of replacing a newer preference with an older source answer. Decide who owns the next permitted action before assigning the inquiry.

If multiple offices or agent groups operate under the buyer, clarify whether they constitute one recipient under the supplier’s agreement and how internal access is controlled. Use a common suppression process across those groups. A shared lead should not become a reason for separate agents in the same organization to initiate overlapping outreach without knowing what colleagues have already done.

Track allocation questions, missing evidence, invalid contact details, and consumer response as different issues. A consumer who chooses another agency is not necessarily a defective inquiry. Conversely, a reachable consumer does not resolve an allocation or permission problem. Set review criteria that let operations and compliance evaluate the same record without conflating these categories.

When comparing shared and exclusive intake, consider differences in staffing, routing, source questions, and outreach process. Keep purchase specifications visible beside results. Do not attribute an observed difference to sharing alone when the campaigns differ in other ways. The practical decision is whether your agency can handle this distribution model responsibly under its written acceptance and contact standards.

Require the actual consent text, consent timestamp, source page URL, and captured IP address with the acquisition record. Read what the consumer agreed to, which organizations or categories it identifies, and which contact methods it addresses. A field marked “consented” is not a substitute for the underlying evidence. Check applicable federal and state requirements, suppression obligations, and any restrictions affecting the intended outreach. Obtain qualified compliance review where interpretation is needed.

Keep acquisition evidence separate from agent notes, but link both through a stable record identifier. For recorded calls, establish who records, how required recording notices or consent are handled, how recordings are retrieved, and who may access them. Recording availability does not establish permission for later calls or messages. If evidence is incomplete or inconsistent, hold the record rather than asking an agent to infer permission.

Medicare AEP runs October 15–December 7. Medicare Advantage OEP runs January 1–March 31 and is not available as a universal enrollment period. T65 and SEP eligibility must be established individually, even when the source includes a timing label.

Buyers must be licensed and verified in the consumer’s state before receiving work intended for insurance solicitation. Confirm product authority, appointment requirements where applicable, and the agency’s supervision process. Do not present the supplier, buyer, or outreach as affiliated with the government. A prospect label is not proof of program eligibility, enrollment rights, coverage needs, or willingness to buy. Agents must establish relevant facts through an appropriate conversation and approved processes.